MLMSX
Price
$25.73
Change
+$0.04 (+0.16%)
Updated
Jul 10 closing price
Net Assets
66.05M
NPFFX
Price
$74.69
Change
+$0.01 (+0.01%)
Updated
Jul 10 closing price
Net Assets
170.23B
Interact to see
Advertisement

MLMSX vs NPFFX

MLMSX vs NPFFX Comparison Chart in %
View a ticker or compare two or three
VS
MLMSX vs. NPFFX commentary
Jul 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLMSX is a Buy and NPFFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFFX has more cash in the bank: 170B vs. MLMSX (66M). NPFFX pays higher dividends than MLMSX: NPFFX (0.92) vs MLMSX (0.10). MLMSX was incepted earlier than NPFFX: MLMSX (10 years) vs NPFFX (25 years). MLMSX (16.59) is less costly to investors than NPFFX (0.77). MLMSX is a more actively managed with annual turnover of: 39.00 vs. NPFFX (23.00). NPFFX has a lower initial minimum investment than MLMSX: NPFFX (250) vs MLMSX (5000000). MLMSX annual gain was more profitable for investors over the last year : 13.37 vs. NPFFX (8.18). MLMSX return over 5 years is better than : 45.69 vs. NPFFX (14.70).
MLMSXNPFFXMLMSX / NPFFX
Total Expense Ratio0.950.77123%
Annual Report Gross Expense Ratio16.590.772,155%
Fund Existence10 years25 years-
Gain YTD6.3226.71594%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets66M170B0%
Annual Yield % from dividends0.100.9211%
Returns for 1 year13.378.18164%
Returns for 3 years59.6339.48151%
Returns for 5 years45.6914.70311%
Returns for 10 years166.62111.81149%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREIX196.620.84
+0.43%
T. Rowe Price Equity Index 500
ABWAX16.700.05
+0.30%
AB All Market Total Return A
TRSLX6.470.01
+0.15%
Transamerica Small Cap Value R
IEOTX17.76N/A
N/A
Voya Large Cap Growth Port S2
CIPIX21.33N/A
N/A
Champlain Mid Cap Institutional